News Image

Turnstone Biologics Announces Plans to Explore Strategic Alternatives

Provided By GlobeNewswire

Last update: Feb 4, 2025

SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX) today announced that it has completed an assessment of its business and operations, including the status of its program, resources, and capabilities. The Company has made the determination to discontinue all clinical studies evaluating TIDAL-01 and halt further development of the program. As a result, Turnstone’s management and its Board of Directors have initiated a process to explore and review strategic alternatives focused on maximizing shareholder value.

Read more at globenewswire.com

TURNSTONE BIOLOGICS CORP

NASDAQ:TSBX (6/11/2025, 8:23:30 PM)

After market: 0.3667 +0.01 (+1.86%)

0.36

0 (-0.8%)



Find more stocks in the Stock Screener

TSBX Latest News and Analysis

ChartMill News Image8 days ago - ChartmillWhich stocks have an unusual volume on Wednesday?

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

Mentions: MODV BMEA KPRX REVB ...

Follow ChartMill for more